Emerson Exchange 365
Search
Sign-In / Register
Site
Search
Sign-In/Register
Services
Products
Control & Safety Systems
Asset Management
Measurement Instrumentation
Valves, Actuators & Regulators
Fluid Control & Pneumatics
Electrical Components & Lighting
Welding, Assembly & Cleaning
IIoT & Digital Transformation
Industries
Chemical
Food and Beverage
Industrial Energy
Life Sciences
Oil & Gas
Power
Refining
Other Industries
Women in STEM
Events
Düsseldorf 2024
Immerse - Anaheim 2023
Grapevine 2022
Nashville 2019
San Antonio 2018
The Hague 2018
World
China
South Korea
Russia
More
Cancel
Industries
More
Life Sciences
Life Sciences Blog
Justifying New Tech Investment When the Plant Is Running Full Out
Forums
Blog
Library/Resources
Members
Tags
More
Cancel
Create New Post
Comment or Question? Become a member of this Emerson Exchange 365 group. Click here to join.
Jim Cahill
15 Apr 2013
biotech manufacturing
Life Sciences
Michalle Adkins
PharmaEvolution.com
automation project justification
pharmaceutical manufacturing
Options
Subscribe by email
RSS
More
Cancel
Related
Recommended
Share
Justifying New Tech Investment When the Plant Is Running Full Out
I wanted to share my guest post over at the PharmaEvolution.com blog, Justifying New Tech Investment When the Plant Is Running Full Out. It can often be challenging to justify investing in new technology when a plant has spare capacity, as Michalle Adkins...
Read the full text.